Stock Events

Bio-Rad Laboratories 

€256
90
+€0+0% Friday 13:29

统计数据

当日最高
256
当日最低
256
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
7.34B
市盈率
-
股息收益率
-
股息
-

收益

7May已确认
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
2.15
2.63
3.11
3.59
预期每股收益
2.15
实际每股收益
2.29

人们还关注

此列表基于关注BUW.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Show more...
首席执行官
Mr. Norman D. Schwartz
员工
8000
国家
US
ISIN
US0905721082
WKN
000862449

上市公司